Skip to main content
Log in

Generics push HIV drug costs down, but new drugs still pricey

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Untangling the Web of ARV Price Reductions

Reference

  • Medecins Sans Frontieres/Doctors Without Borders. Generic competition pushing down HIV drug prices, but patents keep newer drugs unaffordable. Media Release : 2 Jul 2013. Available from: URL: http://www.msfaccess.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Generics push HIV drug costs down, but new drugs still pricey. PharmacoEcon Outcomes News 682, 1 (2013). https://doi.org/10.1007/s40274-013-0526-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0526-z

Navigation